Bharat Biotech's Covaxin will be approved for emergency use by the WHO's Technical Advisory Group today
The technical panel had previously requested further explanations from Bharat Biotech to complete a final risk-benefit analysis for global use of the vaccine.
/connect-gujarat-english/media/post_banners/fa930fbce6c46666c4587a5c763311c67692a86a41d4bd6e21968558695a8e8e.webp)
/connect-gujarat-english/media/post_banners/f53c123d0a03de53363152fcc77048b1ea5287454367ea919ab32b4ee9eb6543.webp)
/connect-gujarat-english/media/post_banners/121a0a64d863d4506b357274eac66b413ef3ba85392a4cf4dd5a7c4ccd2016b7.webp)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/04/5-33.jpg)
/connect-gujarat-english/media/post_banners/wp-content/uploads/2021/03/4-45.jpg)